 | • レポートコード：GIR-107A14564 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、GABA受容体アゴニスト薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。GABA受容体アゴニスト薬の種類別市場規模（バマルゾール、フェニバット、バクロフェン、ガボクサドール、クロナゼパム（クロナゼパム）、ティアグビン）、用途別市場規模（注意欠陥多動性障害（ADHD）、精神障害＆うつ病、アルツハイマー、てんかん＆発作、不安＆睡眠障害、肥満＆アルコール依存症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・GABA受容体アゴニスト薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Advicenne、AstraZeneca、Athena Drug Delivery Solutions、Biocodex、Elan Corporation、Eli Lilly and Company、H.LundBeck, Merck and Co、GlaxoSmithKline、NovaDel Pharma、Novartis、OVATION Pharmaceuticals、Osmotica Pharmaceutical、Pfizer、sanofi-aventis、VIVUS、XenoPort ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：バマルゾール、フェニバット、バクロフェン、ガボクサドール、クロナゼパム（クロナゼパム）、ティアグビン ・用途別分析2016年-2026年：注意欠陥多動性障害（ADHD）、精神障害＆うつ病、アルツハイマー、てんかん＆発作、不安＆睡眠障害、肥満＆アルコール依存症 ・GABA受容体アゴニスト薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・GABA受容体アゴニスト薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・GABA受容体アゴニスト薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・GABA受容体アゴニスト薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・GABA受容体アゴニスト薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The GABA Receptor Agonist Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global GABA Receptor Agonist Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global GABA Receptor Agonist Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
GABA Receptor Agonist Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bamaluzole
Phenibut
Baclofen
Gaboxadol
Klonopin (clonazepam)
Tiagbine
Market segment by Application can be divided into
Attention Deficit Hyperactivity Disorder (ADHD)
Psychiatric Disorders and Depression
Alzheimer
Epilepsy and Seizure
Anxiety and Sleep Disorders
Obesity and Alcoholism
The key market players for global GABA Receptor Agonist Drug market are listed below:
Advicenne
AstraZeneca
Athena Drug Delivery Solutions
Biocodex
Elan Corporation
Eli Lilly and Company
H.LundBeck, Merck and Co
GlaxoSmithKline
NovaDel Pharma
Novartis
OVATION Pharmaceuticals
Osmotica Pharmaceutical
Pfizer
sanofi-aventis
VIVUS
XenoPort
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe GABA Receptor Agonist Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of GABA Receptor Agonist Drug, with price, sales, revenue and global market share of GABA Receptor Agonist Drug from 2019 to 2021.
Chapter 3, the GABA Receptor Agonist Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GABA Receptor Agonist Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and GABA Receptor Agonist Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe GABA Receptor Agonist Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 GABA Receptor Agonist Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global GABA Receptor Agonist Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Bamaluzole
1.2.3 Phenibut
1.2.4 Baclofen
1.2.5 Gaboxadol
1.2.6 Klonopin (clonazepam)
1.2.7 Tiagbine
1.3 Market Analysis by Application
1.3.1 Overview: Global GABA Receptor Agonist Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Attention Deficit Hyperactivity Disorder (ADHD)
1.3.3 Psychiatric Disorders and Depression
1.3.4 Alzheimer
1.3.5 Epilepsy and Seizure
1.3.6 Anxiety and Sleep Disorders
1.3.7 Obesity and Alcoholism
1.4 Global GABA Receptor Agonist Drug Market Size & Forecast
1.4.1 Global GABA Receptor Agonist Drug Sales in Value (2016-2026))
1.4.2 Global GABA Receptor Agonist Drug Sales in Volume (2016-2026)
1.4.3 Global GABA Receptor Agonist Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global GABA Receptor Agonist Drug Production Capacity Analysis
1.5.1 Global GABA Receptor Agonist Drug Total Production Capacity (2016-2026)
1.5.2 Global GABA Receptor Agonist Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 GABA Receptor Agonist Drug Market Drivers
1.6.2 GABA Receptor Agonist Drug Market Restraints
1.6.3 GABA Receptor Agonist Drug Trends Analysis
2 Manufacturers Profiles
2.1 Advicenne
2.1.1 Advicenne Details
2.1.2 Advicenne Major Business
2.1.3 Advicenne GABA Receptor Agonist Drug Product and Services
2.1.4 Advicenne GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca GABA Receptor Agonist Drug Product and Services
2.2.4 AstraZeneca GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Athena Drug Delivery Solutions
2.3.1 Athena Drug Delivery Solutions Details
2.3.2 Athena Drug Delivery Solutions Major Business
2.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product and Services
2.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Biocodex
2.4.1 Biocodex Details
2.4.2 Biocodex Major Business
2.4.3 Biocodex GABA Receptor Agonist Drug Product and Services
2.4.4 Biocodex GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Elan Corporation
2.5.1 Elan Corporation Details
2.5.2 Elan Corporation Major Business
2.5.3 Elan Corporation GABA Receptor Agonist Drug Product and Services
2.5.4 Elan Corporation GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business
2.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Product and Services
2.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 H.LundBeck, Merck and Co
2.7.1 H.LundBeck, Merck and Co Details
2.7.2 H.LundBeck, Merck and Co Major Business
2.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product and Services
2.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Product and Services
2.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 NovaDel Pharma
2.9.1 NovaDel Pharma Details
2.9.2 NovaDel Pharma Major Business
2.9.3 NovaDel Pharma GABA Receptor Agonist Drug Product and Services
2.9.4 NovaDel Pharma GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis GABA Receptor Agonist Drug Product and Services
2.10.4 Novartis GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 OVATION Pharmaceuticals
2.11.1 OVATION Pharmaceuticals Details
2.11.2 OVATION Pharmaceuticals Major Business
2.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product and Services
2.11.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Osmotica Pharmaceutical
2.12.1 Osmotica Pharmaceutical Details
2.12.2 Osmotica Pharmaceutical Major Business
2.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product and Services
2.12.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business
2.13.3 Pfizer GABA Receptor Agonist Drug Product and Services
2.13.4 Pfizer GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 sanofi-aventis
2.14.1 sanofi-aventis Details
2.14.2 sanofi-aventis Major Business
2.14.3 sanofi-aventis GABA Receptor Agonist Drug Product and Services
2.14.4 sanofi-aventis GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 VIVUS
2.15.1 VIVUS Details
2.15.2 VIVUS Major Business
2.15.3 VIVUS GABA Receptor Agonist Drug Product and Services
2.15.4 VIVUS GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 XenoPort
2.16.1 XenoPort Details
2.16.2 XenoPort Major Business
2.16.3 XenoPort GABA Receptor Agonist Drug Product and Services
2.16.4 XenoPort GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 GABA Receptor Agonist Drug Sales by Manufacturer
3.1 Global GABA Receptor Agonist Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global GABA Receptor Agonist Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in GABA Receptor Agonist Drug
3.4 Market Concentration Rate
3.4.1 Top 3 GABA Receptor Agonist Drug Manufacturer Market Share
3.4.2 Top 6 GABA Receptor Agonist Drug Manufacturer Market Share
3.5 Global GABA Receptor Agonist Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and GABA Receptor Agonist Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global GABA Receptor Agonist Drug Market Size by Region
4.1.1 Global GABA Receptor Agonist Drug Sales in Volume by Region (2016-2026)
4.1.2 Global GABA Receptor Agonist Drug Revenue by Region (2016-2026)
4.2 North America GABA Receptor Agonist Drug Revenue (2016-2026)
4.3 Europe GABA Receptor Agonist Drug Revenue (2016-2026)
4.4 Asia-Pacific GABA Receptor Agonist Drug Revenue (2016-2026)
4.5 South America GABA Receptor Agonist Drug Revenue (2016-2026)
4.6 Middle East and Africa GABA Receptor Agonist Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global GABA Receptor Agonist Drug Sales in Volume by Type (2016-2026)
5.2 Global GABA Receptor Agonist Drug Revenue by Type (2016-2026)
5.3 Global GABA Receptor Agonist Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global GABA Receptor Agonist Drug Sales in Volume by Application (2016-2026)
6.2 Global GABA Receptor Agonist Drug Revenue by Application (2016-2026)
6.3 Global GABA Receptor Agonist Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America GABA Receptor Agonist Drug Sales by Type (2016-2026)
7.2 North America GABA Receptor Agonist Drug Sales by Application (2016-2026)
7.3 North America GABA Receptor Agonist Drug Market Size by Country
7.3.1 North America GABA Receptor Agonist Drug Sales in Volume by Country (2016-2026)
7.3.2 North America GABA Receptor Agonist Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe GABA Receptor Agonist Drug Sales by Type (2016-2026)
8.2 Europe GABA Receptor Agonist Drug Sales by Application (2016-2026)
8.3 Europe GABA Receptor Agonist Drug Market Size by Country
8.3.1 Europe GABA Receptor Agonist Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe GABA Receptor Agonist Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific GABA Receptor Agonist Drug Sales by Type (2016-2026)
9.2 Asia-Pacific GABA Receptor Agonist Drug Sales by Application (2016-2026)
9.3 Asia-Pacific GABA Receptor Agonist Drug Market Size by Region
9.3.1 Asia-Pacific GABA Receptor Agonist Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific GABA Receptor Agonist Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America GABA Receptor Agonist Drug Sales by Type (2016-2026)
10.2 South America GABA Receptor Agonist Drug Sales by Application (2016-2026)
10.3 South America GABA Receptor Agonist Drug Market Size by Country
10.3.1 South America GABA Receptor Agonist Drug Sales in Volume by Country (2016-2026)
10.3.2 South America GABA Receptor Agonist Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa GABA Receptor Agonist Drug Sales by Type (2016-2026)
11.2 Middle East & Africa GABA Receptor Agonist Drug Sales by Application (2016-2026)
11.3 Middle East & Africa GABA Receptor Agonist Drug Market Size by Country
11.3.1 Middle East & Africa GABA Receptor Agonist Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa GABA Receptor Agonist Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 GABA Receptor Agonist Drug Typical Distributors
12.3 GABA Receptor Agonist Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global GABA Receptor Agonist Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global GABA Receptor Agonist Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Advicenne Basic Information, Manufacturing Base and Competitors
Table 4. Advicenne Major Business
Table 5. Advicenne GABA Receptor Agonist Drug Product and Services
Table 6. Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca GABA Receptor Agonist Drug Product and Services
Table 10. AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Athena Drug Delivery Solutions Basic Information, Manufacturing Base and Competitors
Table 12. Athena Drug Delivery Solutions Major Business
Table 13. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product and Services
Table 14. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Biocodex Basic Information, Manufacturing Base and Competitors
Table 16. Biocodex Major Business
Table 17. Biocodex GABA Receptor Agonist Drug Product and Services
Table 18. Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Elan Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Elan Corporation Major Business
Table 21. Elan Corporation GABA Receptor Agonist Drug Product and Services
Table 22. Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Company Major Business
Table 25. Eli Lilly and Company GABA Receptor Agonist Drug Product and Services
Table 26. Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. H.LundBeck, Merck and Co Basic Information, Manufacturing Base and Competitors
Table 28. H.LundBeck, Merck and Co Major Business
Table 29. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product and Services
Table 30. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline Major Business
Table 33. GlaxoSmithKline GABA Receptor Agonist Drug Product and Services
Table 34. GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. NovaDel Pharma Basic Information, Manufacturing Base and Competitors
Table 36. NovaDel Pharma Major Business
Table 37. NovaDel Pharma GABA Receptor Agonist Drug Product and Services
Table 38. NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Novartis Basic Information, Manufacturing Base and Competitors
Table 40. Novartis Major Business
Table 41. Novartis GABA Receptor Agonist Drug Product and Services
Table 42. Novartis GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. OVATION Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. OVATION Pharmaceuticals Major Business
Table 45. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product and Services
Table 46. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Osmotica Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Osmotica Pharmaceutical Major Business
Table 49. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product and Services
Table 50. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Pfizer Basic Information, Manufacturing Base and Competitors
Table 52. Pfizer Major Business
Table 53. Pfizer GABA Receptor Agonist Drug Product and Services
Table 54. Pfizer GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. sanofi-aventis Basic Information, Manufacturing Base and Competitors
Table 56. sanofi-aventis Major Business
Table 57. sanofi-aventis GABA Receptor Agonist Drug Product and Services
Table 58. sanofi-aventis GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. VIVUS Basic Information, Manufacturing Base and Competitors
Table 60. VIVUS Major Business
Table 61. VIVUS GABA Receptor Agonist Drug Product and Services
Table 62. VIVUS GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. XenoPort Basic Information, Manufacturing Base and Competitors
Table 64. XenoPort Major Business
Table 65. XenoPort GABA Receptor Agonist Drug Product and Services
Table 66. XenoPort GABA Receptor Agonist Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global GABA Receptor Agonist Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 68. Global GABA Receptor Agonist Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in GABA Receptor Agonist Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global GABA Receptor Agonist Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 71. Head Office and GABA Receptor Agonist Drug Production Site of Key Manufacturer
Table 72. GABA Receptor Agonist Drug New Entrant and Capacity Expansion Plans
Table 73. GABA Receptor Agonist Drug Mergers & Acquisitions in the Past Five Years
Table 74. Global GABA Receptor Agonist Drug Sales by Region (2016-2021e) & (K Pcs)
Table 75. Global GABA Receptor Agonist Drug Sales by Region (2021-2026) & (K Pcs)
Table 76. Global GABA Receptor Agonist Drug Revenue by Region (2016-2021e) & (USD Million)
Table 77. Global GABA Receptor Agonist Drug Revenue by Region (2021-2026) & (USD Million)
Table 78. Global GABA Receptor Agonist Drug Sales by Type (2016-2021e) & (K Pcs)
Table 79. Global GABA Receptor Agonist Drug Sales by Type (2021-2026) & (K Pcs)
Table 80. Global GABA Receptor Agonist Drug Revenue by Type (2016-2021e) & (USD Million)
Table 81. Global GABA Receptor Agonist Drug Revenue by Type (2021-2026) & (USD Million)
Table 82. Global GABA Receptor Agonist Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 83. Global GABA Receptor Agonist Drug Price by Type (2021-2026) & (USD/Pcs)
Table 84. Global GABA Receptor Agonist Drug Sales by Application (2016-2021e) & (K Pcs)
Table 85. Global GABA Receptor Agonist Drug Sales by Application (2021-2026) & (K Pcs)
Table 86. Global GABA Receptor Agonist Drug Revenue by Application (2016-2021e) & (USD Million)
Table 87. Global GABA Receptor Agonist Drug Revenue by Application (2021-2026) & (USD Million)
Table 88. Global GABA Receptor Agonist Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 89. Global GABA Receptor Agonist Drug Price by Application (2021-2026) & (USD/Pcs)
Table 90. North America GABA Receptor Agonist Drug Sales by Country (2016-2021e) & (K Pcs)
Table 91. North America GABA Receptor Agonist Drug Sales by Country (2021-2026) & (K Pcs)
Table 92. North America GABA Receptor Agonist Drug Revenue by Country (2016-2021e) & (USD Million)
Table 93. North America GABA Receptor Agonist Drug Revenue by Country (2021-2026) & (USD Million)
Table 94. North America GABA Receptor Agonist Drug Sales by Type (2016-2021e) & (K Pcs)
Table 95. North America GABA Receptor Agonist Drug Sales by Type (2021-2026) & (K Pcs)
Table 96. North America GABA Receptor Agonist Drug Sales by Application (2016-2021e) & (K Pcs)
Table 97. North America GABA Receptor Agonist Drug Sales by Application (2021-2026) & (K Pcs)
Table 98. Europe GABA Receptor Agonist Drug Sales by Country (2016-2021e) & (K Pcs)
Table 99. Europe GABA Receptor Agonist Drug Sales by Country (2021-2026) & (K Pcs)
Table 100. Europe GABA Receptor Agonist Drug Revenue by Country (2016-2021e) & (USD Million)
Table 101. Europe GABA Receptor Agonist Drug Revenue by Country (2021-2026) & (USD Million)
Table 102. Europe GABA Receptor Agonist Drug Sales by Type (2016-2021e) & (K Pcs)
Table 103. Europe GABA Receptor Agonist Drug Sales by Type (2021-2026) & (K Pcs)
Table 104. Europe GABA Receptor Agonist Drug Sales by Application (2016-2021e) & (K Pcs)
Table 105. Europe GABA Receptor Agonist Drug Sales by Application (2021-2026) & (K Pcs)
Table 106. Asia-Pacific GABA Receptor Agonist Drug Sales by Region (2016-2021e) & (K Pcs)
Table 107. Asia-Pacific GABA Receptor Agonist Drug Sales by Region (2021-2026) & (K Pcs)
Table 108. Asia-Pacific GABA Receptor Agonist Drug Revenue by Region (2016-2021e) & (USD Million)
Table 109. Asia-Pacific GABA Receptor Agonist Drug Revenue by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific GABA Receptor Agonist Drug Sales by Type (2016-2021e) & (K Pcs)
Table 111. Asia-Pacific GABA Receptor Agonist Drug Sales by Type (2021-2026) & (K Pcs)
Table 112. Asia-Pacific GABA Receptor Agonist Drug Sales by Application (2016-2021e) & (K Pcs)
Table 113. Asia-Pacific GABA Receptor Agonist Drug Sales by Application (2021-2026) & (K Pcs)
Table 114. South America GABA Receptor Agonist Drug Sales by Country (2016-2021e) & (K Pcs)
Table 115. South America GABA Receptor Agonist Drug Sales by Country (2021-2026) & (K Pcs)
Table 116. South America GABA Receptor Agonist Drug Revenue by Country (2016-2021e) & (USD Million)
Table 117. South America GABA Receptor Agonist Drug Revenue by Country (2021-2026) & (USD Million)
Table 118. South America GABA Receptor Agonist Drug Sales by Type (2016-2021e) & (K Pcs)
Table 119. South America GABA Receptor Agonist Drug Sales by Type (2021-2026) & (K Pcs)
Table 120. South America GABA Receptor Agonist Drug Sales by Application (2016-2021e) & (K Pcs)
Table 121. South America GABA Receptor Agonist Drug Sales by Application (2021-2026) & (K Pcs)
Table 122. Middle East & Africa GABA Receptor Agonist Drug Sales by Country (2016-2021e) & (K Pcs)
Table 123. Middle East & Africa GABA Receptor Agonist Drug Sales by Country (2021-2026) & (K Pcs)
Table 124. Middle East & Africa GABA Receptor Agonist Drug Revenue by Country (2016-2021e) & (USD Million)
Table 125. Middle East & Africa GABA Receptor Agonist Drug Revenue by Country (2021-2026) & (USD Million)
Table 126. Middle East & Africa GABA Receptor Agonist Drug Sales by Type (2016-2021e) & (K Pcs)
Table 127. Middle East & Africa GABA Receptor Agonist Drug Sales by Type (2021-2026) & (K Pcs)
Table 128. Middle East & Africa GABA Receptor Agonist Drug Sales by Application (2016-2021e) & (K Pcs)
Table 129. Middle East & Africa GABA Receptor Agonist Drug Sales by Application (2021-2026) & (K Pcs)
Table 130. Direct Channel Pros & Cons
Table 131. Indirect Channel Pros & Cons
Table 132. GABA Receptor Agonist Drug Typical Distributors
Table 133. GABA Receptor Agonist Drug Typical Customers
List of Figures
Figure 1. GABA Receptor Agonist Drug Picture
Figure 2. Global GABA Receptor Agonist Drug Sales Market Share by Type in 2020
Figure 3. Bamaluzole
Figure 4. Phenibut
Figure 5. Baclofen
Figure 6. Gaboxadol
Figure 7. Klonopin (clonazepam)
Figure 8. Tiagbine
Figure 9. Global GABA Receptor Agonist Drug Sales Market Share by Application in 2020
Figure 10. Attention Deficit Hyperactivity Disorder (ADHD)
Figure 11. Psychiatric Disorders and Depression
Figure 12. Alzheimer
Figure 13. Epilepsy and Seizure
Figure 14. Anxiety and Sleep Disorders
Figure 15. Obesity and Alcoholism
Figure 16. Global GABA Receptor Agonist Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 17. Global GABA Receptor Agonist Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. Global GABA Receptor Agonist Drug Sales (2016-2026) & (K Pcs)
Figure 19. Global GABA Receptor Agonist Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 20. Global GABA Receptor Agonist Drug Production Capacity (2016-2026) & (K Pcs)
Figure 21. Global GABA Receptor Agonist Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 22. GABA Receptor Agonist Drug Market Drivers
Figure 23. GABA Receptor Agonist Drug Market Restraints
Figure 24. GABA Receptor Agonist Drug Market Trends
Figure 25. Global GABA Receptor Agonist Drug Sales Market Share by Manufacturer in 2020
Figure 26. Global GABA Receptor Agonist Drug Revenue Market Share by Manufacturer in 2020
Figure 27. GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. Top 3 GABA Receptor Agonist Drug Manufacturer (Revenue) Market Share in 2020
Figure 29. Top 6 GABA Receptor Agonist Drug Manufacturer (Revenue) Market Share in 2020
Figure 30. Global GABA Receptor Agonist Drug Sales Market Share by Region (2016-2026)
Figure 31. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2016-2026)
Figure 32. North America GABA Receptor Agonist Drug Revenue (2016-2026) & (USD Million)
Figure 33. Europe GABA Receptor Agonist Drug Revenue (2016-2026) & (USD Million)
Figure 34. Asia-Pacific GABA Receptor Agonist Drug Revenue (2016-2026) & (USD Million)
Figure 35. South America GABA Receptor Agonist Drug Revenue (2016-2026) & (USD Million)
Figure 36. Middle East & Africa GABA Receptor Agonist Drug Revenue (2016-2026) & (USD Million)
Figure 37. Global GABA Receptor Agonist Drug Sales Market Share by Type (2016-2026)
Figure 38. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2016-2026)
Figure 39. Global GABA Receptor Agonist Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 40. Global GABA Receptor Agonist Drug Sales Market Share by Application (2016-2026)
Figure 41. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2016-2026)
Figure 42. Global GABA Receptor Agonist Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 43. North America GABA Receptor Agonist Drug Sales Market Share by Type (2016-2026)
Figure 44. North America GABA Receptor Agonist Drug Sales Market Share by Application (2016-2026)
Figure 45. North America GABA Receptor Agonist Drug Sales Market Share by Country (2016-2026)
Figure 46. North America GABA Receptor Agonist Drug Revenue Market Share by Country (2016-2026)
Figure 47. United States GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe GABA Receptor Agonist Drug Sales Market Share by Type (2016-2026)
Figure 51. Europe GABA Receptor Agonist Drug Sales Market Share by Application (2016-2026)
Figure 52. Europe GABA Receptor Agonist Drug Sales Market Share by Country (2016-2026)
Figure 53. Europe GABA Receptor Agonist Drug Revenue Market Share by Country (2016-2026)
Figure 54. Germany GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific GABA Receptor Agonist Drug Revenue Market Share by Region (2016-2026)
Figure 63. China GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Korea GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America GABA Receptor Agonist Drug Sales Market Share by Type (2016-2026)
Figure 70. South America GABA Receptor Agonist Drug Sales Market Share by Application (2016-2026)
Figure 71. South America GABA Receptor Agonist Drug Sales Market Share by Country (2016-2026)
Figure 72. South America GABA Receptor Agonist Drug Revenue Market Share by Country (2016-2026)
Figure 73. Brazil GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Application (2016-2026)
Figure 77. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Country (2016-2026)
Figure 78. Middle East & Africa GABA Receptor Agonist Drug Revenue Market Share by Country (2016-2026)
Figure 79. Turkey GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Egypt GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Saudi Arabia GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. South Africa GABA Receptor Agonist Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
世界の注意欠陥多動性障害市場 2021：企業別、地域別、種類・用途別 The Attention Deficit Hyperactivity Disorder market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- 世界の注意欠陥多動性障害治療市場 2021：企業別、地域別、種類・用途別 The Attention Deficit Hyperactivity Disorder Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- 世界のグルカゴン様ペプチド-2（GLP-2）アゴニスト市場 2021：企業別、地域別、種類・用途別 The Glucagon-like Peptide-2 (GLP-2) Agonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界のGABA市場 2021：企業別、地域別、種類・用途別 The GABA market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent develo…
- 世界のα1アドレナリン作動薬市場 2021：企業別、地域別、種類・用途別 The α1 Adrenergic Agonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…